Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
基本信息
- 批准号:6630988
- 负责人:
- 金额:$ 31.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-01-15 至 2008-03-31
- 项目状态:已结题
- 来源:
- 关键词:MCF7 cell antisense nucleic acid atomic force microscopy breast neoplasms circular dichroism electron microscopy fluorescence spectrometry gene expression gene therapy genetic transcription genetically modified animals high performance liquid chromatography laboratory mouse light scattering messenger RNA neoplasm /cancer therapy neoplastic cell northern blottings nucleic acid metabolism nucleic acid structure oligonucleotides polyamines protooncogene transfection western blottings
项目摘要
DESCRIPTION (provided by applicant): The overall goal of this project is to elucidate the mechanism of action of polyamine analogues in facilitating the uptake and function of antisense oligonucleotides (ODNs). The hypothesis is that the selectivity of polyamine analogues in DNA condensation and/or stabilization of RNA.DNA hybrids can be utilized to facilitate the cellular uptake and function antisense ODNs for breast cancer therapy. Antisense ODNs targeted to c-myc and HER-2 genes will be studied. To evaluate the structural specificity effects of polyamine analogues on RNA.DNA hybrid stabilization, association constants will be determined using a molecular beacon technique. The role of ODN nanoparticles in facilitating cellular uptake of ODNs will be quantified by dynamic light scattering as well as electron, scanning force and polarizing spectroscopy. Cellular uptake and function of ODNs will be measured using MCF-7 and SK-BR-3 breast cancer cells. ODN uptake will be determined using radioactive and fluorescent ODNs. Effects of polyamine analogue/ODN combinations on target gene expression, cell growth arrest, and apoptosis will be examined to demonstrate enhanced function of ODNs. Subsequently, HER-2 gene targeted ODN and selected polyamine analogues will be examined for in vivo ODN delivery and function using a transgenic mouse model of breast cancer. The effects of polyamine analogues and ODNs on natural polyamines will be quantified by HPLC. These studies will advance our knowledge of the mechanism of cellular uptake of ODNs, and help to develop novel approaches for breast cancer therapy.
描述(由申请人提供):该项目的总体目标是阐明多胺类似物促进反义寡核苷酸(ODN)的摄取和功能的作用机制。假设是,多胺类似物在 DNA 缩合和/或 RNA.DNA 杂交体稳定中的选择性可用于促进细胞摄取和发挥反义 ODN 的功能,用于乳腺癌治疗。将研究针对 c-myc 和 HER-2 基因的反义 ODN。为了评估多胺类似物对 RNA.DNA 杂交稳定性的结构特异性影响,将使用分子信标技术确定关联常数。 ODN 纳米颗粒在促进细胞摄取 ODN 方面的作用将通过动态光散射以及电子、扫描力和偏振光谱进行量化。将使用 MCF-7 和 SK-BR-3 乳腺癌细胞测量 ODN 的细胞摄取和功能。 ODN 摄取量将使用放射性和荧光 ODN 来确定。将检查多胺类似物/ODN 组合对靶基因表达、细胞生长停滞和细胞凋亡的影响,以证明 ODN 的增强功能。随后,将使用乳腺癌转基因小鼠模型检查 HER-2 基因靶向 ODN 和选定的多胺类似物的体内 ODN 递送和功能。多胺类似物和 ODN 对天然多胺的影响将通过 HPLC 进行定量。这些研究将增进我们对 ODN 细胞摄取机制的了解,并有助于开发乳腺癌治疗的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TJ THOMAS其他文献
TJ THOMAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TJ THOMAS', 18)}}的其他基金
Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
- 批准号:
7939375 - 财政年份:2009
- 资助金额:
$ 31.21万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6633220 - 财政年份:2000
- 资助金额:
$ 31.21万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6376346 - 财政年份:2000
- 资助金额:
$ 31.21万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6748436 - 财政年份:2000
- 资助金额:
$ 31.21万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6443430 - 财政年份:2000
- 资助金额:
$ 31.21万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6449297 - 财政年份:2000
- 资助金额:
$ 31.21万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6513053 - 财政年份:2000
- 资助金额:
$ 31.21万 - 项目类别:
POLYAMINE ANALOGS IN ANTI GENE THERAPY FOR BREAST CANCER
乳腺癌抗基因疗法中的多胺类似物
- 批准号:
6200101 - 财政年份:2000
- 资助金额:
$ 31.21万 - 项目类别:
Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
- 批准号:
6873439 - 财政年份:1999
- 资助金额:
$ 31.21万 - 项目类别:
Novel Oligonucleotide Delivery Vehicles for Gene Tharapy
用于基因治疗的新型寡核苷酸递送载体
- 批准号:
6889575 - 财政年份:1999
- 资助金额:
$ 31.21万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 31.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 31.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 31.21万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 31.21万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 31.21万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 31.21万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 31.21万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 31.21万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)